コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 llular LBPs such as serum albumin and plasma retinol binding protein.
2 yx in a manner similar to retinol binding in retinol-binding protein.
3 ne tetramer of TTR can bind two molecules of retinol-binding protein.
4 bundant substrate: retinol bound to cellular retinol-binding protein.
5 Here we show that mouse and human SAAs are retinol binding proteins.
6 it upon ligand binding by mammalian cellular retinol-binding proteins.
7 hibitor families, as well as fatty acid- and retinol-binding proteins.
9 orage, and metabolism of retinoids, cellular retinol-binding protein 1 (CRBP1) is essential for traff
11 romising therapeutic strategy, with cellular retinol-binding protein 1 (RBP1) emerging as a potential
12 in, and desmin, and negatively with cellular retinol-binding protein 1 and matrix metalloproteinase 2
13 on, retinol-related genes such as CRABP2 and retinol-binding protein 1 were overexpressed in WT, and
14 eased markers of dedifferentiation, cellular retinol-binding protein 1, and matrix metalloproteinase
17 uced by immunization with interphotoreceptor retinol-binding protein 1177-1191 peptide were treated b
18 loped an ON-switch system in which the human retinol binding protein 4 (hRBP4) of the lipocalin famil
21 are located near the transthyretin (TTR) and retinol binding protein 4 (RBP4) genes which encode majo
22 retinol (vitamin A) and its binding protein retinol binding protein 4 (RBP4) have been linked to pro
24 causes insulin resistance in human body and Retinol Binding Protein 4 (RBP4) is currently considered
26 onally, 14 significantly lowers murine serum retinol binding protein 4 (RBP4) levels despite a lack o
27 lective increase in plasma and intra-adipose retinol binding protein 4 (RBP4) that preceded obesity.
28 sed in the vascular endothelial cells, while retinol binding protein 4 (rbp4) was expressed in the yo
30 l-trans-retinol (1) delivered via a tertiary retinol binding protein 4 (RBP4)-transthyretin (TTR)-ret
32 L-HDLs showed a reduced content of lipocalin retinol binding protein 4 and apolipoprotein M and in th
33 echanistic studies linking retinol and RBP4 (retinol binding protein 4) to the pathogenesis of cardio
38 escent protein (GFP), siderocalin (Scn), and retinol-binding protein 4 (RBP4) as model proteins and s
39 investigate the mechanisms by which elevated retinol-binding protein 4 (RBP4) causes insulin resistan
42 onsiderable evidence that both retinoids and retinol-binding protein 4 (RBP4) contribute to the devel
52 (a(1) -m), B(2) -microglobulin (B(2) -m) and retinol-binding protein 4 (RBP4) urine concentrations.
53 -m), beta(2) -microglobulin (beta(2) -m) and retinol-binding protein 4 (RBP4) urine concentrations.
54 bition of the retinol-induced interaction of retinol-binding protein 4 (RBP4) with transthyretin (TTR
55 onizing the retinol-dependent interaction of retinol-binding protein 4 (RBP4) with transthyretin in t
58 etinol is not mobilized into circulation via retinol-binding protein 4 (RBP4), and genetic ablation o
61 a genetic model of obesity, plasma levels of retinol-binding protein 4 were higher but bisretinoids i
62 adipocytokines (interleukin-6, adiponectin, retinol-binding protein 4) or soluble intercellular adhe
63 variate analysis) determinant of circulating retinol-binding protein 4, a reliable proxy for retinol
64 itively associated with albuminuria, urinary retinol-binding protein 4, LV mass, and type 2 diabetes
65 h a diet high in fat presented with elevated retinol-binding protein 4, the protein responsible for t
66 e show, using DNA arrays, that expression of retinol binding protein-4 (RBP4) is elevated in adipose
67 s of TNF-alpha, IL-6, adiponectin, resistin, retinol binding protein-4, or intraabdominal fat volume.
68 high-molecular-weight adiponectin, resistin, retinol binding protein-4, or intraabdominal obesity, su
72 our serum proteins-carcinoembryonic antigen, retinol binding protein, alpha1-antitrypsin, and squamou
73 the fatty acid binding proteins and cellular retinol binding protein also are down-regulated in the a
76 usly quantifying iron (ferritin), vitamin A (retinol-binding protein), and inflammation (C-reactive p
81 m constitutive hepatic proteins (prealbumin, retinol-binding protein, and transferrin) increased with
82 annexins, transthyretins, nematode-specific retinol-binding proteins, and SCP/TAPS were identified.
83 enases (RoDH), which recognize holo-cellular retinol-binding protein as substrate, had been cloned, e
84 , malate dehydrogenase 1 cytoplasmic, plasma retinol-binding protein, biotinidase, and transferrin, a
85 ions with both unbound and CRBP(I) (cellular retinol-binding protein)-bound retinal, but apo-CRBP(I)
87 Km of approximately 0.7 microM, and cellular retinol-binding protein-bound retinal, with a Km of appr
88 esponse tests work on the principle that apo-retinol-binding protein builds up in the liver as liver
89 y using high-pressure liquid chromatography, retinol-binding protein by using ELISA, and alanine amin
91 and serum amyloid-A and an increase in serum retinol-binding protein compared with placebo (p < .05).
96 toward retinoids in the presence of cellular retinol-binding protein (CRBP) type I or cellular retina
97 e lipid-binding protein (KLBP), the cellular retinol-binding protein (CRBP), and the cellular retinoi
98 ic-acid-binding protein (CRABP) and cellular retinol-binding protein (CRBP), as well as their relatio
99 RA biosynthesis pathway consists of cellular retinol-binding protein (Crbp), retinol dehydrogenase (D
105 ow that Rald is present in rodent fat, binds retinol-binding proteins (CRBP1, RBP4), inhibits adipoge
106 In vivo, retinoids are bound to cellular retinol-binding proteins (CRBPs) and cellular retinoic a
107 ol), and proximal renal tubular dysfunction (retinol-binding protein/creatinine ratio >2.93mug/mmol a
108 n causes distal bowel aganglionosis in serum retinol-binding-protein-deficient (Rbp4(-/-)) mice.
110 ein II (CRBP II) is a member of the cellular retinol-binding protein family, which is expressed prima
111 ate eyes acquires vitamin A from circulating retinol binding protein for chromophore biosynthesis.
113 tamin A is transported in the blood bound to retinol-binding protein (holo-RBP), and its target cells
115 ding serum retinol binding protein, cellular retinol binding protein I and cellular retinol binding p
117 cyl chloromethyl ketone (AcDCMK) or cellular retinol-binding protein I (CRBP) diminished the generati
120 e structure and dynamics of rat apo-cellular retinol binding protein II (apo-CRBP II) in solution has
121 protein cavity, we redesigned human cellular retinol binding protein II (hCRBPII) to fully encapsulat
122 cid increases the mRNA level of the cellular retinol binding protein II and the rate of retinol uptak
123 lular retinol binding protein I and cellular retinol binding protein II have been disrupted by homolo
124 ationally engineered protein (human cellular retinol binding protein II, hCRBPII) and different fluor
125 inol-binding protein I (CRBP I) and cellular retinol-binding protein II (CRBP II) are closely homolog
128 e and backbone dynamics of rat holo cellular retinol-binding protein II (holo-CRBP II) in solution ha
129 a dimer of dimers, transports thyroxine and retinol binding protein in blood plasma and cerebrospina
130 fter CM-RE uptake, the levels of retinol and retinol-binding protein in serum, and retinoid levels in
131 mechanism for the uptake of retinol bound to retinol-binding protein in the small intestine of suckli
133 s (ferritin, serum transferrin receptor, and retinol binding protein) in settings of prevalent inflam
134 d missense mutations in RBP4, encoding serum retinol binding protein, in three families with eye malf
136 is transported to and taken up by the eye by retinol-binding protein-independent and retinoic acid-re
137 the ability of M-TTR to form a complex with retinol binding protein, indicate that M-TTR forms a ter
138 we show that serum amyloid A (SAA) proteins retinol-binding proteins induced in intestinal epithelia
139 me oxygenase-1 (HO-1) and interphotoreceptor retinol binding protein (IRBP) were determined 1 to 2 da
142 5 ng/mL or 32 pmol/L), vitamin A deficiency (retinol-binding protein <14.7 mug/mL or 0.70 mumol/L) an
144 luded height for age at 10 weeks, vitamin D, retinol binding protein, maternal education, household i
145 <15 ng/mL for women), vitamin A deficiency (retinol-binding protein or retinol <20.1 ug/dL), inflamm
146 le transferrin receptor or vitamin A status (retinol-binding protein or retinol)] and >/=1 biomarker
147 uch as the transporter of thyroxine and holo retinol-binding protein or transthyretin (TTR) functioni
148 ons as the high-affinity receptor for plasma retinol binding protein (RBP) and mediates cellular upta
149 nitially assessed for vitamin A status using retinol binding protein (RBP) and modified relative dose
152 transports vitamin A from its blood carrier retinol binding protein (RBP) into cells, and it also fu
155 s transported in the blood as a complex with retinol binding protein (RBP), but the molecular mechani
157 hemoglobin, ferritin, transferrin receptors, retinol binding protein (RBP), zinc, selenium, and vitam
159 ular-weight proteins beta2-microglobulin and retinol binding protein (RBP)], although other measures
160 tinol, but there was a 7% increase in plasma retinol-binding protein (RBP) and a 56% reduction in vit
162 have higher plasma ferritin (pF), and lower retinol-binding protein (RBP) and zinc (pZn) concentrati
163 reported previously that mice lacking plasma retinol-binding protein (RBP) are phenotypically normal
164 Binding of the natural ligands thyroxine or retinol-binding protein (RBP) by Ser52Pro variant TTR st
166 The molten globule state of human serum retinol-binding protein (RBP) has been postulated previo
168 ate uptake of retinol from its blood carrier retinol-binding protein (RBP) into cells and to function
173 erum ferritin, soluble transferrin receptor, retinol-binding protein (RBP), 25-hydroxy vitamin D, fol
174 s, respectively: serum retinol, 90% and 78%; retinol-binding protein (RBP), 40% and 91%; retinol/RBP
175 aditional RDR test, could be circumvented if retinol-binding protein (RBP), a more stable marker of V
176 oss of CMOI function studies in mice lacking retinol-binding protein (RBP), an established model of e
178 ombinant vitamin A serum transport proteins, retinol-binding protein (RBP), and transthyretin (TTR),
179 inol is transported around the body bound to retinol-binding protein (RBP), is transferred across the
189 molecule metabolically interacting with TTR [retinol-binding protein (RBP)], for possible association
190 on retinyl esters (CM-REs), retinol bound to retinol-binding protein (RBP-ROH), and total retinol wer
192 etinoid-binding protein (IRBP, also known as retinol-binding protein, RBP3), which enables the physic
193 f mice with a pNO(2)Phe(43) mutant of murine retinol-binding protein (RBP4) also elicited a high tite
199 Our aim was to elucidate the role of the retinol-binding protein receptor STRA6, mediating cellul
201 ncreased expression of the gene encoding the retinol-binding protein receptor Stra6L, which, in turn,
202 ascade, suppressed CRBP-I/RARalpha (cellular retinol-binding protein/retinoic acid receptor alpha) ex
203 entify SAAs as a family of microbe-inducible retinol binding proteins, reveal a unique protein archit
204 id (P-MMA), plasma folate (P-Fol), and serum retinol-binding protein (S-RBP) were measured at inclusi
205 media did not result from increased retinol-retinol-binding protein secretion but was dependent on t
206 least one retinoid binding protein (cellular retinol binding protein) serves as a retinoid concentrat
209 retinoid-binding protein (IRBP) or cellular retinol-binding protein, suggesting that peropsin plays
211 binding protein (CRBP)-III, an intracellular retinol-binding protein that is expressed solely in hear
212 (beta2-microglobulin to creatinine ratio and retinol-binding protein to creatinine ratio) improved or
213 nstitutive serum protein levels (prealbumin, retinol binding protein, transferrin) and decreased seru
214 riptionally up-regulated by RA, the cellular retinol binding protein type I (CRBPI) and the RA recept
216 by the enterocyte is complexed with cellular retinol-binding protein type 2 and the complex serves as
218 etinol oxidation in the presence of cellular retinol-binding protein type I (CRBPI) than human micros
220 esence of a 10-fold molar excess of cellular retinol-binding protein type I, which is believed to seq
221 9cRA)-inducible enhancer of the rat cellular retinol-binding protein type II gene (CRBP II) was shown
222 ulation (3-4-fold) in the level of cytosolic retinol-binding protein type III (CRBPIII) in adipose ti
226 -binding protein, type I (CrbpI), encoded by retinol-binding protein, type 1 (Rbp1), is a chaperone o
227 -binding protein, type 1 (CRBP1), encoded by retinol-binding protein, type 1 (Rbp1), regulates RA hom
235 and the correlation between elevated urinary retinol-binding protein-urinary creatinine ratio (uRBP/u
236 friendly approaches are hemoglobin (anemia), retinol-binding protein (vitamin A), and iron (transferr
238 toichiometry of three interacting molecules, retinol-binding protein, vitamin A, and L-thyroxine, not
242 reception in mice, animals mutated in plasma retinol binding protein were placed on a vitamin A-free
244 therefore represents a novel class of small retinol-binding protein, which appears to be confined to